readthroughSign in
CompanyNONOFNVONYSE, OTCBagsvaerd Denmark, G7

Novo Nordisk A/S

Novo Nordisk develops insulin and other treatments for diabetes and obesity.

8-KNov 17Latest SEC filing
Nov 16Latest story

November 2026

October 2026

September 2026

August 2026

July 2026